A. Torres (Barcelona, Spain), F. Paganin (St Pierre, France)
Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study)
L. Molinos, A. Torres, J. Zalacain, R. Menendez, L. Borderias, J. Ruiz, M. Garcia (Oviedo, Barcelona, Baracaldo, Valencia, Huesca, Badalona, Mieres, Spain)
|  |
Interim results of the Greatest International ANti-infective Trial (GIANT) in patients with AECB
A. Anzueto, D. Legnani, M. Miravitlles, H. Landen, K. Stauch (Texas, United States Of America; Milan, Italy; Barcelona, Spain; Leverkusen, Germany)
| |
Efficacy and safety of levofloxacin treatment of community-acquired pneumonia in hospitalized patients
K. J. Karwat, E. M. Grabczak, R. Chazan (Warsaw, Poland)
| |
Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients
M. N. Mily, S. A. Golubev, M. M. Sachek (Vitebsk, Belarus)
| |
Amoxicillin with clavulanic acid in empiric therapy of community acquired pneumonia - retrospective analysis
P. Dziklinska, A. D. Barela, R. Chazan (Warsaw, Poland)
| |
The efficiency of moxifloxacin (MOX) in community-acquired pneumonias (CAP) treatment while the initial antibacterial therapy (IAT) was inefficient
R. O. Bontsevych, T. O. Pertseva (Dniepropetrovsk, Ukraine)
| |
Ertapenem therapy for community-acquired pneumonia in the elderly
A. K. Zacharof, C. L. Flevaris, C. L. Petrogiannopoulos, G. N. Karachalios, G. H. Svoukas, C. Kanakis (Athens, Greece)
| |
Determinants of performance of indicators on antibiotic use in community-acquired pneumonia (CAP) at hospitals
J. A. Schouten, M. E. J. L. Hulscher, J. W. M. van der Meer, R. P. T. M. Grol (Nijmegen, Netherlands)
| |
Efficacy of combined therapy in severe community-acquired pneumonia (CAP) with efferent detoxication methods (EDM) vs. standard therapy by antibiotics (STA)
A. E. Makarevich, J. J. Pancratova, B. V. Kirkovsky (Minsk, Belarus)
| |
Comparative activity of telithromycin against Streptococcus pneumoniae in Europe: update from PROTEKT Year 4 (2002–2003)
F. Blasi, D. J. Farrell (Milan, Italy; London, United Kingdom)
| |
Use of diagnostic tests and antibiotics in community-acquired pneumonia
A. C. Elliott, A. Janjua, A. G. Wardman (Wigan, United Kingdom)
| |
Infective agents and their antibiotic susceptibility in patients with respiratory infections
O. V. Plekhanova (Dniepropetrovsk, Ukraine)
| |
Fluoroquionolone-resistant strains of Streptococcus pneumoniae at the Far East of Russia
A. V. Martynova, A. A. Scheparjov, V. B. Turcutjukov (Vladivostok, Russian Federation)
| |
Frequency of isolation of resistant strains of bacteria in pulmonology hospital
A. M. Zalutskaya, E. R. Sahalchyk, L. K. Surkova (Minsk, Belarus)
| |
Evolution of antimicrobial resistance trends in the last five years in patients with bacteremic Pneumococcal community-acquired pneumonia (CAP-SP)
O. Rajas, J. Aspa, C. De las Cuevas, B. Buendia, E. Antón, A. Casanova, J. García Gonzalez, E. Pérez Amor, J. Ancochea (Madrid, Spain)
| |
Emergence of penicillin resistant Streptococcus pneumoniae in Pakistan
T. Kulsoom, K. Jabeen, R. Hasan (Karachi, Pakistan)
| |
Streptococcus pneumoniae antibiotic resistance from 1986 to 2004
J. Tarrega, C. Marti, M. Torrella, E. Barbeta (Granollers, Spain)
| |
Resistance to antimicrobial agents in patients with non-cystic fibrosis (CF) bronchiectasis
C. M. Monaghan, G. Antunes, H. R. Gribbin, S. A. Murphy (Middlesbrough, United Kingdom)
| |
The results of bronchoscopy used in the examination and treatment of patients with community acquired pneumonia
V. A. Kasantsev (St. Petersburg, Russian Federation)
| |
Pharmacoepidemiology of antibiotics using for treatment severe pulmonary infections in a clinical city hospital
A. I. Karlov, V. V. Arkhipov, N. B. Lazareva (Moscow, Russian Federation)
| |